Blog Archives
The Pharmaceutical Industry
Poison Pill centers around a hospital internist who discovers a common thread between the cases of two young patients who present with serious health issues. What was the inspiration for the setup of your story?
Believe it or not, the ultimate inspiration for this novel goes all the way back to a single day in medical school. During my second-year pharmacology course, there was one lecture that departed from the usual lectures on pharmaceutical drugs. It presented an introductory overview of major herbal supplements, not to turn us medical students into herbal experts, but to let us know what else is out there. That, in turn, got me curious about the parallel industry of herbal medicine and the differences between that industry and the pharmaceutical industry. One of the biggest differences is related to regulation: pharmaceutical products undergo a stringent approval process through the Food and Drug Administration (FDA), yet the FDA treats herbal supplements the same way they do foods, so that regulations for those products are more lax.
Many years later, when it came time for me to write my third Mark Lin medical thriller, I knew I had to touch upon these two topics. Plenty of past medical thrillers have already tackled the pharmaceutical industry alone, and few have taken on herbal medicine. As far as I know, there isn’t another medical thriller where both the herbaceutical and pharmaceutical industries are presented in parallel within the same novel, in order for readers to compare and contrast the two. I like to think of myself as a trailblazer with this type of story in the genre.
Can you share with us a little about the research required to get the medical aspects of your storyline just right?
With any medical thriller I write, my research involves reviewing facts about the medical conditions I feature in the story, plus stuff about nonmedical topics that are integrated into the plot. For Poison Pill, that means ensuring no factual inaccuracies related to, for example, kidney failure and atherosclerosis, as well as certain procedures with the FDA. Also, I took a look at where things stood with weight loss medications, so that incorporating references to Ozempic and Wegovy in this novel grounded the story in realism and achieved the feeling that the story’s events could very well come true. Interestingly enough, the fictional pharmaceutical weight loss drug and its manufacturer in my novel, Naxipil by Tixerix Pharmaceuticals, is an oral GLP-1 medication, and this comes on the heels of real-life oral weight loss medications hitting the market to replace injectable weight loss drugs.
What is one thing you hope readers take away from Poison Pill?
I hope that readers understand that medicine has risks, whether they are herbal supplements or pharmaceuticals. Herbal supplements may seem safe because they are natural, but that is not always true. Pharmaceuticals may seem safe because they undergo a rigid FDA approval process, but side effects can still come to light in postmarket surveillance. In the end, is one form of medicine really better than the other, or are they just equally risky in different ways?
Can you give us a peek inside the next book in the Dr. Mark Lin Medical Thrillers series? Where will it take readers?
Usually, I prefer not to go into plot specifics for a novel I am writing until I officially unveil it for preordering. What I will do, though, is provide a vague and general overview of what this next book entails.
The upcoming fourth novel of the Dr. Mark Lin Medical Thrillers series will be a two-part saga where the events of the first part lay the groundwork for events in the second part. It will also dive into two kinds of issues where the world of medicine crosses into other professions. Specifically, one deals with medicolegal matters, and the other looks at medicine crossing paths with the world of business and finance. I am sure that readers will enjoy brainstorming the many possibilities of what this will entail. But rest assured. The story I have in mind is one that I believe will be very thrilling because it’s highly original. It’s another medical thriller tale that has never been written before, by any author, and I intended to be the first to tell it.
Author Links: GoodReads | Website | Amazon
Dr. Mark Lin hates greedy drug companies, along with herbal supplements that can sometimes do more harm than good. Two medical mysteries force him to confront both.
First, a young man, only in his twenties, suffers from debilitating kidney failure. The only clue is his use of a mysterious herbal product for weight loss. Meanwhile, a patient has trouble breathing for unclear reasons, though Mark worries about the anti-obesity drug he started taking. Things truly get nightmarish when one of those pills strikes with lethal force, compelling Mark to take action.
Mark now finds himself navigating a web of deceit within the shadows of two rival industries: herbaceutical and pharmaceutical. He will uncover secrets about their so-called miracle cures, confront a company spokesman, and face a pair of aggressive salespeople. But once he puts everything on the line and discovers the true conspiracy, his only mission is to prevent catastrophic death, not just for the public but also himself.
Poison Pill is Anthony Lee’s medical thriller tackling dual methods of healing and the shady practices that do real harm to everyday people.
Poison Pill
Poison Pill is a medical thriller that follows Dr. Mark Lin, a hospital internist in Southern California, after two young patients land in his care with problems that feel too extreme, too early: a 24-year-old in kidney failure and a severely obese man with worsening breathing issues. When Mark notices a common thread, both men have been using weight-loss products, one an herbal supplement called Motileaf and the other a prescription drug called Naxipil, his curiosity turns into an off-the-clock investigation that pulls him from hospital rounds into supplement shops, corporate hallways, and a much bigger fight over how “help” gets sold, regulated, and sometimes weaponized.
What I liked right away is how the book opens with the body, not the conspiracy. There’s this clear-eyed attention to blood, organs, and the quiet terror of hearing a patient ask if they’re going to die. The medical detail is frequent and confident, but it usually lands in a way that serves the tension instead of showing off. You can almost smell the dialysis unit and feel the fluorescent stillness of a hospital hallway. And the first-person voice works here. Mark can be compassionate with patients, prickly with colleagues, and blunt in his private thoughts, sometimes all in the same scene. That mix made him feel authentic to me, which matters in a genre where the lead can easily turn into a walking lab coat.
Author Anthony Lee also makes a deliberate choice to bring the reader into the systems around medicine, not just the bedside moments. You get a lot about how herbal supplements slide through looser oversight, how pharma messaging moves, and how “evidence” can be both a shield and a sales tool. The plot escalates the way good thrillers do: one unsettling link becomes two, then suddenly Mark is watching the supply chain and realizing how many hands touch a “simple” capsule before it reaches someone’s kitchen counter. The story occasionally pauses to explain processes and terminology, which will work for some readers, but I found it mostly grounded because it’s framed as how a clinician thinks when the pattern won’t let go.
Poison Pill reminds me of author Tess Gerritsen, where the pace comes from a doctor pushing past polite boundaries because the official story does not add up, like in Harvest. And if you like Michael Crichton’s “this could actually happen” vibe, especially the procedural, systems-focused suspense of The Andromeda Strain, Lee’s interest in process, oversight, and unintended consequences will feel familiar, just grounded more in everyday medicine and consumer health than in big sci-fi set pieces.
I’d recommend Poison Pill to readers who like medical thrillers with a strong “how did this happen” spine, especially if you enjoy stories that blend clinical realism with corporate and regulatory pressure. If you’re into slow-burn unease that builds into a wider conspiracy, and you don’t mind learning a little along the way, this one will hit the spot.
Pages: 383 | ASIN : B0GGZG155T
